Toxicological effects of diquat on the central nervous system and associated treatment challenges

Xinyu Wang1, Yunxia Liu1, Meng Yang1

  • 1Department of Emergency Medicine, Shengjing Hospital of China Medical University, Tiexi District, No. 39 Huaxiang Road, Shenyang, Liaoning 110000, PR China.

Neurotoxicology
|September 27, 2025
PubMed
Abstract

Insights

Diquat herbicide causes severe central nervous system (CNS) damage through oxidative stress, inflammation, and other molecular pathways. Understanding these mechanisms is crucial for developing effective neuroprotective strategies against diquat poisoning.

Area of Science:

  • Neuroscience
  • Toxicology
  • Pharmacology

Background:

  • Diquat is a highly toxic herbicide with significant central nervous system (CNS) toxicity.
  • Diquat poisoning leads to high mortality and poor neurological outcomes.
  • The molecular mechanisms of diquat-induced CNS damage and neuroprotection are poorly understood.

Purpose of the Study:

  • To systematically review and integrate current knowledge on diquat-induced CNS toxicity.
  • To identify the molecular mechanisms underlying diquat's neurotoxicity.
  • To highlight challenges and future directions for neuroprotection and treatment.

Main Methods:

  • Systematic literature search and screening of 424 retrieved records.
  • Inclusion of 21 articles (11 experimental, 10 case studies).
  • Systematic review approach integrating basic research and clinical evidence.

Main Results:

  • Identified clinical manifestations (impaired consciousness, convulsions, brainstem symptoms) and imaging findings (basal ganglia, brainstem lesions).
  • Highlighted six key molecular mechanisms: oxidative stress, neuroinflammation, autophagy dysfunction, apoptosis, mitochondrial dysfunction, and neurotransmitter alterations.
  • These mechanisms are interrelated, leading to neuronal death and functional impairment.

Conclusions:

  • Diquat induces severe CNS damage via multiple interrelated molecular pathways.
  • Current treatments are challenged by the lack of specific antidotes and targeted neuroprotective agents.
  • Future research should focus on elucidating mechanisms, identifying neuroprotective targets, and optimizing treatment and rehabilitation strategies.

Related Concept Videos

Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
1.5K
Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
1.8K
Prevention of Further Absorption of Poison01:14

Prevention of Further Absorption of Poison

In cases of acute poisoning, the primary objective is to prevent further absorption of the toxic substance into the body. Immediate interventions using various decontamination techniques targeting the gastrointestinal (GI) tract can achieve this. Decontamination is crucial to prevent poison from entering the systemic circulation, which involves washing affected areas with water and mild soap and removing contaminated clothing. Once external decontamination is done, attention must be turned to...
1.2K
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
567
Antidotes01:17

Antidotes

Antidotes are medicinal substances used to counteract the harmful effects of toxins or drugs in the body. They function in various ways, each uniquely designed to combat specific toxic compounds.
Specific antidotes operate by inhibiting the enzymes that control biochemical pathways, reducing the production of harmful metabolites.
An example of an antidote is atropine, which counteracts the detrimental effects of cholinesterase inhibitors. It achieves this by deactivating muscarinic receptors,...
1.0K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
986